Article Text

PDF
MG-107 Congenital sucrase-isomaltase deficiency: Identification of the common inuit founder mutation
  1. Julien L Marcadier1,
  2. Margaret Boland2,3,
  3. C Ronald Scott4,
  4. Kheirie Issa3,
  5. Zaining Wu4,
  6. Adam D McIntyre5,
  7. Robert A Hegele5,
  8. Michael T Geraghty3,6,
  9. Matthew A Lines3,6
  1. 1Department of Genetics, Children’s Hospital of Eastern Ontario, Ottawa, ON, Canada
  2. 2Division of Gastroenterology, Hepatology and Nutrition, Children's Hospital of Eastern Ontario
  3. 3Department of Pediatrics, University of Ottawa and Children's Hospital of Eastern Ontario Research Institute, Ottawa, Canada
  4. 4Department of Pediatrics, University of Washington, Seattle, WA, USA
  5. 5Robarts Research Institute, Schulich School of Medicine and Dentistry, Western University, London, ON, Canada
  6. 6Metabolics, Children’s Hospital of Eastern Ontario, Ottawa, ON, Canada

Abstract

Objective Congenital sucrase-isomaltase deficiency (CSID) is a rare hereditary cause of chronic diarrhoea in children. Persons with CSID lack the intestinal brush-border enzyme required for digestion of di- and oligosaccharides, including sucrose and isomaltose. Malabsorption results in abdominal pain, distention, copious diarrhoea, and failure to thrive. If recognised, dietary avoidance of the offending carbohydrates is highly effective. Although CSID is known to be highly prevalent (˜5–10%) in several Inuit populations, the genetic basis for this condition has not been described.

Methods We sequenced the sucrase-isomaltase gene, SI, in a single Inuit CSID proband with severe fermentative diarrhoea and failure to thrive. We then genotyped a further 128 anonymized Inuit control individuals from a variety of circumpolar locales to assess for a possible founder effect.

Results We identified a novel, homozygous frameshift mutation, c.273_274delAG (p. Gly92Leufs*8) in exon 4 of SI in the proband, that is predicted to result in complete absence of functional protein product. This change is indeed very common among Inuit control specimens, with an observed allele frequency of 0.17 (95% confidence interval 0.13–0.22). The predicted Hardy-Weinberg prevalence of CSID in the Inuit, based on this single founder allele is ˜3% (95% confidence interval 1.6–5.0%), comparable with previous estimates.

Interpretation Targeted mutation testing for the c.273_274delAG allele should afford a simple and minimally invasive means of diagnosing CSID in persons of Inuit descent. Because CSID is a readily treatable disorder, such testing should be considered at an early stage in the assessment of Inuit patients with chronic diarrhoea.

Statistics from Altmetric.com

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.